Ceylan Tanes
Overview
Explore the profile of Ceylan Tanes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
1172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Breton J, Tu V, Tanes C, Wilson N, Quinn R, Kachelries K, et al.
J Crohns Colitis
. 2025 Jan;
19(2).
PMID: 39887086
Background And Aims: Epidemiological studies have suggested an association between the inflammatory potential of dietary patterns and Crohn's disease (CD). However, the relationships of these inflammatory dietary determinants with the...
2.
Benitez A, Tanes C, Friedman E, Zackular J, Ford E, Gerber J, et al.
Microbiome
. 2025 Jan;
13(1):21.
PMID: 39856742
Background: The evolving infant gut microbiome influences host immune development and later health outcomes. Early antibiotic exposure could impact microbiome development and contribute to poor outcomes. Here, we use a...
3.
Barekat K, Ricciotti E, Ghosh S, Herrmann C, Keat K, Assenmacher C, et al.
bioRxiv
. 2024 Dec;
PMID: 39651214
Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most widely used medications for the management of chronic pain; however, they are associated with numerous gastrointestinal (GI) adverse events. Although many mechanisms have...
4.
Soto Ocana J, Friedman E, Keenan O, Bayard N, Ford E, Tanes C, et al.
mBio
. 2024 Oct;
15(11):e0153424.
PMID: 39440978
The gut microbiota plays a critical role in human health and disease. Microbial community assembly and succession early in life are influenced by numerous factors. In turn, assembly of this...
5.
Alameh M, Semon A, Bayard N, Pan Y, Dwivedi G, Knox J, et al.
Science
. 2024 Oct;
386(6717):69-75.
PMID: 39361752
infection (CDI) is an urgent public health threat with limited preventative options. In this work, we developed a messenger RNA (mRNA)-lipid nanoparticle (LNP) vaccine targeting toxins and virulence factors. This...
6.
Tu V, Ren Y, Tanes C, Mukhopadhyay S, Daniel S, Li H, et al.
mSphere
. 2024 Sep;
9(9):e0048824.
PMID: 39230261
Importance: Antibiotics are potent influencers of the human microbiome and can be a source for enduring dysbiosis and antibiotic resistance in healthcare. Existing microbiome data analysis methods can quantify perturbations...
7.
Tanes C, Tu V, Daniel S, Bittinger K
mSystems
. 2024 Jun;
9(7):e0051524.
PMID: 38912768
The method of 16S rRNA marker gene sequencing has fueled microbiome research and continues to be relevant. A perceived weakness of the method is that taxonomic assignments are not possible...
8.
Hecht A, Harling L, Friedman E, Tanes C, Lee J, Firrman J, et al.
J Clin Invest
. 2024 Mar;
134(9).
PMID: 38512401
Bacterial translocation from the gut microbiota is a source of sepsis in susceptible patients. Previous work suggests that overgrowth of gut pathobionts, including Klebsiella pneumoniae, increases the risk of disseminated...
9.
Changes in fecal lipidome after treatment with ivacaftor without changes in microbiome or bile acids
Bass R, Tanes C, Bittinger K, Li Y, Lee H, Friedman E, et al.
J Cyst Fibros
. 2023 Oct;
23(3):481-489.
PMID: 37813785
Background: Alterations in gastrointestinal health are prominent manifestations of cystic fibrosis (CF) and can independently impact pulmonary function. Ivacaftor has been associated with robust improvements in pulmonary function and weight...
10.
Lemons J, Conrad M, Tanes C, Chen J, Friedman E, Roggiani M, et al.
Cell Mol Gastroenterol Hepatol
. 2023 Sep;
17(1):131-148.
PMID: 37739064
Background & Aims: Altered plasma acylcarnitine levels are well-known biomarkers for a variety of mitochondrial fatty acid oxidation disorders and can be used as an alternative energy source for the...